This inventor holds 1 USPTO granted patent. Top assignee: Fundacao Butantan. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mauricio Barbugiani Goldfeder: Innovator in Biochemistry and Molecular Biology
Introduction
Mauricio Barbugiani Goldfeder is a notable inventor based in Vila Mariana, Brazil. He has made significant contributions to the fields of biochemistry, molecular biology, and medicinal chemistry. His work focuses on developing innovative solutions for thromboembolic diseases through recombinant proteins.
Latest Patents
Goldfeder holds a patent for a recombinant protein and its fragments, which includes a method for producing said recombinant protein. The patent details the use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition aimed at the prophylaxis and treatment of thromboembolic diseases. This class of proteins acts as a direct and specific inhibitor of thrombin, which is crucial in managing blood coagulation. His research highlights the potential of these proteins as anticoagulant agents, derived from transcriptomics analysis of the salivary glands of ticks.
Career Highlights
Goldfeder is associated with the Fundação Butantan, a prominent research institution in Brazil. His work there emphasizes the intersection of genetics and pharmacy, contributing to advancements in therapeutic applications. His innovative approach has led to the development of solutions that address critical health issues related to blood clotting.
Collaborations
Goldfeder has collaborated with esteemed colleagues such as Ana Marisa Chudzinski-Tavassi and Asif Iqbal. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.
Conclusion
Mauricio Barbugiani Goldfeder's contributions to biochemistry and molecular biology exemplify the impact of innovative research on healthcare. His patented work on recombinant proteins showcases the potential for new treatments in thromboembolic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
